Document is current
Any future updates will be listed below
-
Authors
Worm, Jacob https://orcid.org/0000-0002-7201-065X
Heinskou, Tone Bruvik https://orcid.org/0000-0002-1318-4262
Rochat, Per
Springborg, Jacob Bertram https://orcid.org/0000-0003-0917-3402
Smilkov, Emil Andonov https://orcid.org/0009-0002-8026-4307
Bendtsen, Lars https://orcid.org/0000-0002-4810-4998
Schytz, Henrik Winther https://orcid.org/0000-0002-6262-2986
Maarbjerg, Stine https://orcid.org/0000-0002-3309-6120
-
Funding
Funding for this research was provided by:
Trigeminus Foreningen
National Hospital
- License Information
-
More Information
Article History
Received: 17 September 2025
Revised: 30 September 2025
Accepted: 4 October 2025
First Online: 16 October 2025
Declarations
:
: JW serves as PI in an RCT sponsored by Noema Pharma, has received a scholarship grant from Copenhagen University Hospital Rigshospitalet, and travel support for congress attendance from Lundbeck and Novartis. LB has given lectures and served on the scientific advisory board for AbbVie, Pfizer, and Teva. HWS has received consultant fees from Lundbeck, Pfizer, AbbVie, Lilly, and Novartis.
